论文信息 - Evolving development of PD-1 therapy: Cetrelimab (JNJ-63723283) from monotherapy to combination with erdafitinib. - 字舞流文

Evolving development of PD-1 therapy: Cetrelimab (JNJ-63723283) from monotherapy to combination with erdafitinib.

B. Mellado | M. Monga | E. Felip | P. Rutkowski | A. Siefker-Radtke | Y. Loriot | I. Durán | S. Tagawa | V. Moreno | J. Greger | S. Siena | S. Akapame | E. Calvo | D. Kowalski | L. Geoffrois | D. Cortinovis | C. Beato | E. Plummer | Anne OHagan | Nebedita Bandyopadhyay